Dr. Ramana Chennubhotla, MD (he/him) is an Endocrinologist, Internist in Elizabethtown, KY with over 17 years of experience. What is your opinion of Dr. Ramana Chennubhotla, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ramana Chennubhotla, MD has received over $75,911 which includes payments from the following companies:
$65,425.03 from Novo Nordisk Inc
$3,214.06 from Medtronic MiniMed, Inc.
$1,064.78 from Janssen Pharmaceuticals, Inc
$929.59 from sanofi-aventis U.S. LLC
$468.08 from LILLY USA, LLC
$447.59 from Boehringer Ingelheim Pharmaceuticals, Inc.
$438.29 from Abbott Laboratories
$411.18 from AbbVie, Inc.
$359.64 from INSULET CORPORATION
$302.52 from Novartis Pharmaceuticals Corporation
$285.20 from Valeritas, Inc.
$248.94 from Amarin Pharma Inc.
$245.06 from AstraZeneca Pharmaceuticals LP
$244.48 from Amneal Pharmaceuticals LLC
$224.74 from GlaxoSmithKline, LLC.
$199.78 from Amgen Inc.
$158.83 from Merck Sharp & Dohme Corporation
$141.81 from Dexcom, Inc.
$137.44 from Radius Health, Inc.
$99.54 from GENZYME CORPORATION
Payments received by Dr. Ramana Chennubhotla, MD were from the following categories:
$53,160.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!